P Van Damme, E Van Doorslaer, G Tormans, P Beutels. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisHepatitis A/prevention & controlHepatitis A VaccinesHepatovirus/immunologyHumansTravelVaccines, InactivatedViral Hepatitis Vaccines/economics
Substances: See more » Hepatitis A VaccinesVaccines, InactivatedViral Hepatitis Vaccines
Year: 1995 PMID: 7866237 PMCID: PMC2548791 DOI: 10.1136/bmj.310.6976.402
Source DB: PubMed Journal: BMJ ISSN: 0959-8138